91 related articles for article (PubMed ID: 6094681)
1. Efficacy of aerosolized recombinant interferons against vesicular stomatitis virus-induced lung infection in cotton rats.
Sun CS; Wyde PR; Wilson SZ; Knight V
J Interferon Res; 1984; 4(4):449-59. PubMed ID: 6094681
[TBL] [Abstract][Full Text] [Related]
2. Duration of effect of interferon aerosol prophylaxis of vesicular stomatitis virus infection in mice.
Wyde PR; Sun CS; Wilson SZ; Knight V
Antimicrob Agents Chemother; 1985 Jan; 27(1):60-4. PubMed ID: 2984982
[TBL] [Abstract][Full Text] [Related]
3. Limited efficacy of aerosolized recombinant alpha interferon against virulent influenza A/HK infection in mice.
Sun CS; Wilson SZ; Wyde PR
Proc Soc Exp Biol Med; 1986 Feb; 181(2):298-304. PubMed ID: 3945639
[TBL] [Abstract][Full Text] [Related]
4. Interferon aerosol suppression of vesicular stomatitis virus replication in the lungs of infected mice.
Wyde PR; Wilson SZ; Sun CS; Knight V
Antimicrob Agents Chemother; 1984 Oct; 26(4):450-4. PubMed ID: 6097164
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary deposition and clearance of aerosolized interferon.
Wyde PR; Wilson SZ; Kramer MJ; Sun CS; Knight V
Antimicrob Agents Chemother; 1984 Jun; 25(6):729-34. PubMed ID: 6742817
[TBL] [Abstract][Full Text] [Related]
6. Cell and virus sensitivity studies with recombinant human alpha interferons.
Kramer MJ; Dennin R; Kramer C; Jones G; Connell E; Rolon N; Gruarin A; Kale R; Trown PW
J Interferon Res; 1983; 3(4):425-35. PubMed ID: 6323591
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic alpha interferon treatment increases the therapeutic index of oncolytic vesicular stomatitis virus virotherapy for advanced hepatocellular carcinoma in immune-competent rats.
Shinozaki K; Ebert O; Suriawinata A; Thung SN; Woo SL
J Virol; 2005 Nov; 79(21):13705-13. PubMed ID: 16227290
[TBL] [Abstract][Full Text] [Related]
8. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M
J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of interferon action. Interferon alpha inhibits vesicular stomatitis virus primary transcript accumulation in P1/eIF-2 alpha protein kinase-deficient human fibroblast cells.
Zhang XT; Samuel CE
J Biol Regul Homeost Agents; 1987; 1(4):157-65. PubMed ID: 2845723
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cytotoxicity and antiviral activity of recombinant human interferon alfa-2a and recombinant human interferon alfa-B/D hybrid against bovine viral diarrhea virus, infectious bovine rhinotracheitis virus, and vesicular stomatitis virus in vitro.
Peek SF; Bonds MD; Gangemi DG; Thomas CB; Schultz RD
Am J Vet Res; 2004 Jun; 65(6):871-4. PubMed ID: 15198231
[TBL] [Abstract][Full Text] [Related]
11. Anti-HIV-1 activity of recombinant and hybrid species of interferon-alpha.
Sperber SJ; Gocke DJ; Haberzettl C; Kuk R; Schwartz B; Pestka S
J Interferon Res; 1992 Oct; 12(5):363-8. PubMed ID: 1331260
[TBL] [Abstract][Full Text] [Related]
12. Activity of human recombinant and lymphoblastoid interferons in human and heterologous cell lines.
Overall JC; Yeh TJ; Kern ER
J Interferon Res; 1984; 4(4):529-33. PubMed ID: 6094683
[TBL] [Abstract][Full Text] [Related]
13. Treatment with human recombinant leukocyte interferons inhibits in vitro invasive ability of human lung carcinoma cells.
Ravine TJ; Ledinko N
Clin Exp Metastasis; 1986; 4(3):191-203. PubMed ID: 2427270
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human interferon-alpha A treatment of an experimental cutaneous herpes simplex virus type 1 infection of guinea pigs.
Freeman DJ; McKeough MB; Spruance SL
J Interferon Res; 1987 Apr; 7(2):213-22. PubMed ID: 3039015
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of the interferon-mediated antiviral state to vesicular stomatitis virus in resting mouse peritoneal macrophages.
Di Francesco P; Coccia EM; Gessani S; Romeo G; Borghi P; Locardi C; Belardelli F
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1899-905. PubMed ID: 2544669
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined alpha IFN and prostaglandin A1 treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells.
Pica F; Rossi A; Santirocco N; Palamara A; Garaci E; Santoro MG
Antiviral Res; 1996 Mar; 29(2-3):187-98. PubMed ID: 8739598
[TBL] [Abstract][Full Text] [Related]
17. Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells.
Wollmann G; Robek MD; van den Pol AN
J Virol; 2007 Feb; 81(3):1479-91. PubMed ID: 17108037
[TBL] [Abstract][Full Text] [Related]
18. Rat interferons. VI. Heterologous interferon in the treatment of viral infections.
Lobodzińska M; Albin M
Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):247-52. PubMed ID: 220932
[TBL] [Abstract][Full Text] [Related]
19. Concomitant TLR/RLH signaling of radioresistant and radiosensitive cells is essential for protection against vesicular stomatitis virus infection.
Spanier J; Lienenklaus S; Paijo J; Kessler A; Borst K; Heindorf S; Baker DP; Kröger A; Weiss S; Detje CN; Staeheli P; Kalinke U
J Immunol; 2014 Sep; 193(6):3045-54. PubMed ID: 25127863
[TBL] [Abstract][Full Text] [Related]
20. Experimental vesicular stomatitis virus infection of swine: extent of infection and immunological response.
Redelman D; Nichol S; Klieforth R; Van Der Maaten M; Whetstone C
Vet Immunol Immunopathol; 1989 Mar; 20(4):345-61. PubMed ID: 2470190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
